Discover how scientists are harnessing the power of CRISPR to precisely edit DNA, revolutionizing medicine and ethics as they rewrite the very code of life. Pixabay, PublicDomainPictures CRISPR ...

Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...

The Global Gene Editing Market, valued at USD 4.68 billion in 2023, is poised for transformative growth, projected to expand at a compound annual growth rate (CAGR) of 10.2% through 2033. This dynamic ...

A new research paper was published in Volume 16 of Genes & Cancer on October 31, 2025, titled “P3a site-specific and cassette mutagenesis for seamless protein, RNA and plasmid engineering.” ...

Wildly accurate futuristic warnings wrapped in storytelling that now feels unsettlingly familiar. A gripping selection of sci-fi classics that saw what was coming., Books, Times Now ...

Thus, this new site-specific and cassette mutagenesis method is highly efficient, fast and versatile, likely resulting in its wide use for typical ...

Predictive indicators for whether a baby will be vulnerable to certain diseases after birth, as well as their future height, ...

Rocket Pharmaceuticals advances gene therapies for rare diseases. Momentum aligns with broader biotech trends in the Nasdaq ...

CompletedstrategicpivotfromR&Dfocustocommercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize ...

Scribe Therapeutics Inc. ("Scribe"), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective enough to become standard-of-care ...

Discover how synthetic biology is shaping the future of disease control with genetically modified mosquitoes from Target ...

Phage therapy is reshaping our understanding of how targeted viruses can reset the gut microbiome, offering a precise, ...